Market Overview

UPDATE: Stifel Nicolaus Initiates Patterson Companies at Buy; Discount at Trough

Share:
Related PDCO
Patterson Companies Announces Definitive Agreement to Sell Its Medical Business to Madison Dearborn Partners
Top 4 Stocks In The Medical Equipment Wholesale Industry With The Highest Gross Margin
Patterson unloads medical business to private equity firm for $715M in cash (Seeking Alpha)

Stifel Nicolaus initiated coverage on Patterson Companie (NASDAQ: PDCO) with a Buy rating and a $39 price target.

Stifel Nicolaus noted, "[W]e look forward and believe the current discount is unlikely to widen further and actually may narrow. We point to: (1) Patterson's N.A. consumables showing signs of share stabilization; (2) Patterson's long-term advantage in high-tech dental equipment; (3) an overweighting to N.A. basic equipment, which we view favorably despite near-term pressure; and (4) an overall N.A. dental market that may be poised for a modest recovery."

Patterson Companies closed at $33.99 on Wednesday.

Latest Ratings for PDCO

DateFirmActionFromTo
Dec 2014Bank of AmericaMaintainsBuy
Nov 2014Credit SuisseMaintainsUnderperform
Nov 2014Credit SuisseMaintainsUnderperform

View More Analyst Ratings for PDCO
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (PDCO)

Around the Web, We're Loving...

Get Benzinga's Newsletters